GovChime
Notice ID: 9084ed9ebf04330d912b559e317d34c2Combined Synopsis/Solicitation

65--Telazol - (tiletamine HCL and Zolazepam HCL)

Archived on September 28, 2012. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
7:00 AM UTC+02:00
Posted
August 14, 2012
Notice type
Combined Synopsis/Solicitation
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
325412: Pharmaceutical Preparation Manufacturing
Agency
Department of the InteriorUS FISH AND WILDLIFE SERVICE

Notice details

Office
FWS HEADQUARTERS
PSC
65: MEDICAL/DENTAL/VETERINARY EQPT/SUPP
Last updated
Dec 5, 2025

Identifiers

Solicitation number
F12PS00972
Notice ID
9084ed9ebf04330d912b559e317d34c2

Description

This solicitation is issued as a request for quote (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through the current Federal Acquisition Circular (FAC 2005-60, July 26 18, 2012) and the Federal Acquisition Regulation (FAR). This is set aside 100% for small business. NAICS classification code: 325412 and PSC: 6505. The business size standard is 750. This is a firm fixed price procurement. Quotes will be evaluated by Best Value Determination. Best value determination will be based off of vendor RFQ that can provide delivery within 30 days of order with the latest-possible expiry date, to extend through at least May of 2014. U.S. Fish and Wildlife Service has a controlled substance control officer. NOTICE TO VENDORS: - Any changes to the specifications/statement of work requiring an alteration in performance or delivery schedule requires approval by the Contracting Officer prior to solicitation closing. - For award perspective vendor to have updated and current CCR and ORCA registration. Vendor to provide DUNS number with quote/proposal. - The USFWS has implemented new invoicing procedures. As of November 1, 2011 all invoice must be processed through IPP. See clauses for specific information. PROPOSAL/QUOTE SUBMISSION: Proposals must be received at the following address, via fax, email or mail, prior to the closing date of this solicitation. Closing date of this solicitation is August 29, 2012, 17:00 Eastern Time. US Fish and Wildlife Service Contracting and General Services Attn: Amanda Jordan 1011 E. Tudor Road, MS 171 Anchorage, AK 99503 Phone 907-786-3436 Fax 907-786-3923 Amand_jordan@fws.gov

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Amanda Jordan

Documents

No documents available.

Lifecycle

Solicitation:F12PS00972
  1. Combined Synopsis
  1. Combined SynopsisCurrentAug 14, 2012

    65--Telazol - (tiletamine HCL and Zolazepam HCL)

    Notice 9084ed9ebf04330d912b559e317d34c2 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
MOD for Option Year Two (2) is attached.
56%
AwardedOpen
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract. Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
55%
AwardedOpen
SPE2D2-26-D-0008 Duloxetine HCL DR Award
52%
AwardedOpen
Modification SPE2D223D0007 P00013 No-Cost Settlement Termination for Convenience. Modification SPE2D223D0007 P00012 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification SPE2D223D0007 P00011 to change the Manufacturer, Place of Performance and NDC for Olopatadine HCL 0.1% Ophthalmic Solution 5ML Bottle. Modification SPE2D223D0007 P00010 to update new POC for Golden State Medical Supply, Inc. cage code 1HT23. Modification SPE2D223D0007 P00008 to exercise Option Year 3 effective February 15, 2026 through February 14, 2027. Modification SPE2D223D0007 P00007 is modified in accordance with DoD Class Deviation 2025-O0003. Modification SPE2D223D0007 P00006 to exercise Option Year 2 effective February 15, 2025 through February 14, 2026. Modification SPE2D223D0007 P00005 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract. Modification SPE2D223D0007 P00004 to exercise Option Year 1 effective February 15, 2024 through February 14, 2025. Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle
50%
AwardedOpen
43%
Solicitation11/04/2016

Additional Details

Solicitation Number

F12PS00972

Archive Date

Sep 28, 2012